The use of radiolabeled somatostatin analog scintigraphy in the staging of small cell lung cancer patients

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 5, 2007, Pages 503-506

  Tzannou, Ifigeneia A ^a   Karapanagiotou, Eleni M ^a   Charpidou, Adrianni ^a   Dilana, Kalliopi ^a   Alamara, Christina ^a   Christakopoulou, Ioanna ^a   Georgiou, Evangelos ^b   Syrigos, Konstantinos N ^a,b  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Lung cancer; Octreotide; Receptors; Scintigraphy; Staging

Indexed keywords

PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ABDOMINAL RADIOGRAPHY; ABSENCE OF SIDE EFFECTS; ADRENAL METASTASIS; ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; BRAIN METASTASIS; BRAIN TOMOGRAPHY; BRONCHOSCOPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CERVICAL LYMPH NODE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; DISSEMINATED CANCER; FEMALE; HUMAN; INTERMETHOD COMPARISON; ISOTOPE LABELING; LIVER METASTASIS; LUNG SCINTISCANNING; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY;

ADULT; AGED; CARCINOMA, SMALL CELL; FEMALE; HUMANS; INDIUM RADIOISOTOPES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIONUCLIDE IMAGING; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; SURVIVAL ANALYSIS;

EID: 35148813069     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3180546747     Document Type: Article

References (35)

1. Buccheri G, Ferrigno D. Prognostic factors of small cell lung cancer. Hematol Oncol Clin North Am. 2004;18:445-460.
2. Reubi JC, Kvols LK, Krenning E, et al. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism. 1990;39:78-81.
3. Reubi JC, Waser B, Sheppard M, et al. Somatostatin receptors are present in small-cell but not non-small-cell primary lung carcinomas: relationship to EGF receptors. Int J Cancer. 1990;45:269-274.
4. Reubi JC, Laissue J, Krenning EP, et al. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implication. J Steroid Biochem Mol Biol. 1992;43:27-35.
5. Reubi JC, Krenning E, Lamberts SW, et al. In vitro detection of somatostatin receptors in human tumors. Digestion. 1993;54:76-83.
6. O'Byrne KJ, Halmos G, Pinski J, et al. Somatostatin receptor expression in lung cancer. Eur J Cancer. 1994;30:1682-1687.
7. O'Byrne KJ, Carney DN. Somatostatin and the lung. Lung Cancer. 1993;10:151-172.
8. Prevost G, Bourgeois Y, Mormont C, et al. Characterization of somatostatin receptors and growth inhibition by the somatostatin analog BIM 23014 in small cell lung carcinoma xenograft: SCLC-6. Life Sci. 1994;55:155-162.
9. Taylor JE, Thevaniau MA, Bashirzadeh R, et al. Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity. Peptides. 1994;15:1229-1236.
10. Maini CL, Tofani A, Venturo I, et al. Somatostatin receptor imaging in small cell lung cancer using 111-In-DTPA-Octreotide: a preliminary study. Nucl Med Commun. 1993;14:962-968.
11. Kwekkeboom DJ, Krenning EP. Somatostatin receptor imaging. Semin Nucl Med. 2002;32:84-91.
12. Weiner RE, Thakur ML. Radiolabeled peptides in diagnosis and therapy. Semin Nucl Med. 2001;31:296-311.
13. Weiner RE, Thakur ML. Radiolabeled peptides in diagnosis and therapy of oncological diseases. Appl Radiat Isot. 2002;57:749-763.
14. Papotti M, Croce S, Bello M, et al. Expression of somatostatin receptor types 2,3 and 5 in biopsies and surgical specimens of human lung tumors: correlation with preoperative octreotide scintigraphy. Virchows Arch. 2001;439:787-797.
15. Van der Lely AJ, de Herder WW, Kerning EP. OctreoScan radioreceptor imaging. Endocrine. 2003;20:307-311.
16. Shepherd PA, Ginsberg RJ, Haddad R, et al. Importance of clinical staging in limited small cell lung cancer: a valuable system to separate prognostic subgroups. J Clin Oncol. 1993;8:1592-1597.
17. Smith W, Khuri FR. The care of the lung cancer patient in the 21st century: a new age. Semin Oncol. 2004;31:11-15.
18. Modlin IM, Latich I, Zikusoka M, et al. Gastrointestinal carcinoids: the evolution of diagnostic strategies. J Clin Gastroenterol. 2006;40:572-582.
19. O'Byrne KJ, Carney DN. Radiolabeled somatostatin analog scintigraphy in oncology. Anticancer Drugs. 1996;7(suppl 1):33-44.
20. Lamberts SWJ, Bakker WH, Reubi JC, et al. Somatostatin receptor imaging in the localization of endocrine tumors. N Engl J Med 1990;1246-1249.
21. Lamberts SWJ, Hofland LJ, Van Koetsveld PM, et al. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization and therapy. J Clin Endocrinol Metab. 1990;71:566-574.
22. Kwekkeboom DJ, Krenning EP, Bakker WH, et al. Radioiodinated somatostatin analog scintigraphy in small-cell lung cancer. J Nucl Med. 1991;32:1845-1848.
23. Leitha T, Studnicka M, Marosi M, et al. The role of iodine-123-Tyr-3- octreotide in the staging of small-cell lung cancer. J Nucl Med. 1993;34:1397-1402.
24. Krenning EP, Kwekkeboom DJ, Bakker WH, et al. Somatostatin receptor scintigraphy with (111-In-DTPA-D-Phe) and (123I-Tyr)-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med. 1993;20:716-731.
25. O'Byrne KJ, Ennis JT, Freyne PJ, et al. Scintigraphic imaging of small-cell lung cancer with 111-In-pentetreotide, a radiolabeled somatostatin analogue. Br J Cancer. 1994;69:762-766.
26. O'Byrne KJ, Lyons D, Istarabadi M. Scintigraphy imaging in lung tumors with radiolabeled somatostatin analogs. Nucl Med Commun. 1993;14:234-241.
27. Kirch CM, von Pawel J, Grau J. In-111 pentetreotide in diagnostic work-up of patients with bronchogenic carcinoma. Eur J Nucl Med. 1994;21:1318-1325.
28. Bombanieri E, Crippa F, Cataldo I, et al. Somatostatin receptor imaging in small cell lung cancer by means of 111-In-DTPA-octreotide scintigraphy. Eur J Cancer 1995;31:184-188.
29. Kortum S, Chen T, Rausch V. Scintigraphy with In-111-octreotide in the management of with bronchogenic carcinoma. Eur J Nucl Med. 1994;20:884.
30. Kwekkeboom DJ, Kho GS, Lamberts SW, et al. The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med. 1994;21:1106-1113.
31. Reisinger I, Bohuslavitzki KH, Brenner V, et al. Somatostatin receptor imaging in small-cell lung cancer: results of a multicenter study. J Nucl Med. 1998;39:224-227.
32. Berenger N, Moretti JL, Boaziz C, et al. Somatostatin receptor imaging in small cell lung cancer. Eur J Cancer 1996;32:1429-1431.
33. Bohuslavitzki KH, Brenner V, Gunther M, et al. Somatostatin receptor imaging in small-cell lung cancer. Nucl Med Commun. 1996;17:191-196.
34. Hochstenbag MM, Heidendal GA, Wouters EF, et al. In-111-octreotide imaging in staging of small cell lung cancer. Clin Nucl Med. 1997;22:811-816.
35. Yamada Y, Kagimoto S, Kubota A, et al. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem Biophys Res Commun. 1993;195:844-852.